SCHEMBL1417895

SCHEMBL1417895

CCOC(=O)CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.76
ERBB2 P04626 13/20 0.75
ERBB4 Q15303 6/20 0.75
JAK3 P52333 2/20 0.75
GAK O14976 1/20 0.67
RIPK2 O43353 1/20 0.67
NR1I2 O75469 1/20 0.67
LCK P06239 1/20 0.67
ADORA3 P0DMS8 1/20 0.67
CHRM1 P11229 1/20 0.67
SRC P12931 1/20 0.67
DRD2 P14416 1/20 0.67
ADRA2C P18825 1/20 0.67
SLC6A2 P23975 1/20 0.67
MC3R P41968 1/20 0.67
SLC6A3 Q01959 1/20 0.67
PDE4D Q08499 1/20 0.67
KCNH2 Q12809 1/20 0.67
RIPK3 Q9Y572 1/20 0.67
ERBB3 P21860 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1417893 1.00 EGFR (0.76) EGFRERBB2ERBB4JAK3GAK
SCHEMBL1417903 0.94 EGFR (0.65) EGFRERBB2ERBB4JAK3GAK
SCHEMBL1417904 0.94 EGFR (0.65) EGFRERBB2ERBB4JAK3GAK
SCHEMBL6495901 0.92 EGFR (0.73) EGFRERBB2ERBB4JAK3GAK
SCHEMBL6495898 0.92 EGFR (0.73) EGFRERBB2ERBB4JAK3GAK
SCHEMBL1418219 0.91 EGFR (0.63) EGFRERBB2ERBB4JAK3GAK
SCHEMBL1418217 0.91 EGFR (0.63) EGFRERBB2ERBB4JAK3GAK
SCHEMBL1418794 0.90 EGFR (0.61) EGFRERBB2ERBB4JAK3GAK
SCHEMBL1418793 0.90 EGFR (0.61) EGFRERBB2ERBB4JAK3GAK
SCHEMBL867639 0.90 EGFR (0.85) EGFRERBB2ERBB4JAK3GAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2298746-A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-03-23 EP disclosed
US-6972288-B1 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-12-06 US disclosed